|
2026-08-12 |
2026-08-12 |
PrS
Vente proposée
|
10% Stockholder
Actionnaire important
|
96 642
263,14
2 383 181 $US
|
96 642
|
263,14
|
2 383 181 $US
|
|
|
2026-08-11 |
2026-08-11 |
PrS
Vente proposée
|
Officer
Dirigeant
|
88 343
384,60
359 804 $US
|
88 343
|
384,60
|
359 804 $US
|
|
|
2026-08-05 |
2026-08-03 |
PlS
Vente planifiée
|
SVP, Drug Discovery
Dirigeant
|
13 706
+41.7%
453,43
2 567 391 $US
|
13 706
+41.7%
|
453,43
|
2 567 391 $US
|
|
|
2026-08-05 |
2026-08-03 |
PlS
Vente planifiée
|
SVP, Drug Discovery
Dirigeant
|
1 000
-1.0%
33,98
100 000 $US
|
1 000
-1.0%
|
33,98
|
100 000 $US
|
|
|
2026-07-17 |
2026-07-15 |
PlS
Vente planifiée
|
President and COO
Dirigeant
|
4 000
-2.2%
33,99
135 974 $US
|
4 000
-2.2%
|
33,99
|
135 974 $US
|
|
|
2026-07-15 |
2026-07-15 |
PrS
Vente proposée
|
Officer
Dirigeant
|
4 000
34,54
138 160 $US
|
4 000
|
34,54
|
138 160 $US
|
|
|
2026-07-02 |
2026-07-01 |
PlS
Vente planifiée
|
SVP, Drug Discovery
Dirigeant
|
1 233
-1.3%
34,81
42 926 $US
|
1 233
-1.3%
|
34,81
|
42 926 $US
|
|
|
2026-07-02 |
2026-07-01 |
PlS
Vente planifiée
|
SVP, Drug Discovery
Dirigeant
|
2 100
-2.1%
34,10
71 602 $US
|
2 100
-2.1%
|
34,10
|
71 602 $US
|
|
|
2026-06-30 |
2026-06-29 |
PlS
Vente planifiée
|
Chief People Officer
Dirigeant
|
2 178
-73.3%
35,18
76 622 $US
|
2 178
-73.3%
|
35,18
|
76 622 $US
|
|
|
2026-06-26 |
2026-06-26 |
PrS
Vente proposée
|
Officer
Dirigeant
|
2 438
36,61
89 243 $US
|
2 438
|
36,61
|
89 243 $US
|
|
|
2026-06-24 |
2026-06-22 |
PlS
Vente planifiée
|
SVP, Drug Discovery
Dirigeant
|
7 000
-6.8%
35,97
251 781 $US
|
7 000
-6.8%
|
35,97
|
251 781 $US
|
|
|
2026-06-24 |
2026-06-22 |
PlS
Vente planifiée
|
SVP, Drug Discovery
Dirigeant
|
8 000
-7.2%
35,10
280 801 $US
|
8 000
-7.2%
|
35,10
|
280 801 $US
|
|
|
2026-06-22 |
2026-06-22 |
PrS
Vente proposée
|
Officer
Dirigeant
|
25 000
36,17
904 250 $US
|
25 000
|
36,17
|
904 250 $US
|
|
|
2026-06-22 |
2026-06-22 |
PrS
Vente proposée
|
Officer
Dirigeant
|
25 000
36,17
904 250 $US
|
25 000
|
36,17
|
904 250 $US
|
|
|
2026-06-22 |
2026-06-22 |
PrS
Vente proposée
|
Officer
Dirigeant
|
94 339
35,26
3 326 120 $US
|
94 339
|
35,26
|
3 326 120 $US
|
|
|
2026-06-22 |
2026-06-22 |
PrS
Vente proposée
|
Officer
Dirigeant
|
94 339
35,26
3 326 120 $US
|
94 339
|
35,26
|
3 326 120 $US
|
|
|
2026-06-16 |
2026-06-12 |
PlS
Vente planifiée
|
Chief People Officer
Dirigeant
|
6 250
-88.7%
35,08
219 224 $US
|
6 250
-88.7%
|
35,08
|
219 224 $US
|
|
|
2026-06-12 |
2026-06-12 |
PrS
Vente proposée
|
Officer
Dirigeant
|
8 428
34,03
286 805 $US
|
8 428
|
34,03
|
286 805 $US
|
|
|
2026-06-03 |
2026-06-01 |
PlS
Vente planifiée
|
Chief People Officer
Dirigeant
|
2 889
-78.5%
29,66
85 696 $US
|
2 889
-78.5%
|
29,66
|
85 696 $US
|
|
|
2026-06-03 |
2026-06-01 |
PlS
Vente planifiée
|
Chief People Officer
Dirigeant
|
1 346
-26.8%
28,79
38 755 $US
|
1 346
-26.8%
|
28,79
|
38 755 $US
|
|
|
2026-06-03 |
2026-06-01 |
PlS
Vente planifiée
|
Chief People Officer
Dirigeant
|
1 700
-25.3%
27,78
47 231 $US
|
1 700
-25.3%
|
27,78
|
47 231 $US
|
|
|
2026-05-28 |
2026-05-26 |
PlS
Vente planifiée
|
Chief People Officer
Dirigeant
|
11 798
-93.7%
30,06
354 656 $US
|
11 798
-93.7%
|
30,06
|
354 656 $US
|
|
|
2026-05-26 |
2026-05-26 |
PrS
Vente proposée
|
Officer
Dirigeant
|
11 798
28,36
334 591 $US
|
11 798
|
28,36
|
334 591 $US
|
|
|
2026-04-17 |
2026-04-15 |
PlS
Vente planifiée
|
President and COO
Dirigeant
|
326
-0.2%
25,86
8 431 $US
|
326
-0.2%
|
25,86
|
8 431 $US
|
|
|
2026-04-17 |
2026-04-15 |
PlS
Vente planifiée
|
President and COO
Dirigeant
|
1 101
-0.6%
25,24
27 789 $US
|
1 101
-0.6%
|
25,24
|
27 789 $US
|
|
|
2026-04-17 |
2026-04-15 |
PlS
Vente planifiée
|
President and COO
Dirigeant
|
2 573
-1.4%
23,76
61 124 $US
|
2 573
-1.4%
|
23,76
|
61 124 $US
|
|
|
2026-03-04 |
2026-03-02 |
PlS
Vente planifiée
|
Chief People Officer
Dirigeant
|
66 363
-98.8%
28,14
1 867 342 $US
|
66 363
-98.8%
|
28,14
|
1 867 342 $US
|
|
|
2026-03-04 |
2026-03-02 |
PlS
Vente planifiée
|
Chief People Officer
Dirigeant
|
4 090
-5.7%
27,51
112 496 $US
|
4 090
-5.7%
|
27,51
|
112 496 $US
|
|
|
2026-03-02 |
2026-03-02 |
PrS
Vente proposée
|
Officer
Dirigeant
|
76 388
29,02
2 216 780 $US
|
76 388
|
29,02
|
2 216 780 $US
|
|
|
2026-02-20 |
2026-02-18 |
PlS
Vente planifiée
|
President and COO
Dirigeant
|
1 800
-1.0%
29,58
53 250 $US
|
1 800
-1.0%
|
29,58
|
53 250 $US
|
|
|
2026-02-20 |
2026-02-18 |
PlS
Vente planifiée
|
President and COO
Dirigeant
|
2 200
-1.2%
28,46
62 611 $US
|
2 200
-1.2%
|
28,46
|
62 611 $US
|
|
|
2026-02-18 |
2026-02-18 |
PrS
Vente proposée
|
Officer
Dirigeant
|
8 000
30,30
242 400 $US
|
8 000
|
30,30
|
242 400 $US
|
|
|
2025-11-13 |
2025-11-10 |
PlS
Vente planifiée
|
SVP, Drug Discovery
Dirigeant
|
3 501
-3.6%
18,06
63 223 $US
|
3 501
-3.6%
|
18,06
|
63 223 $US
|
|
|
2025-11-10 |
2025-11-10 |
PrS
Vente proposée
|
Officer
Dirigeant
|
3 501
18,06
63 223 $US
|
3 501
|
18,06
|
63 223 $US
|
|
|
2025-03-10 |
2025-03-07 |
A
Achat
|
Administrateur non-exécutif
|
13 319
+12.8%
6,93
92 270 $US
|
13 319
+12.8%
|
6,93
|
92 270 $US
|
|
|
2025-03-06 |
2025-03-06 |
A
Achat
|
Administrateur non-exécutif
|
41 355
+65.9%
6,00
248 130 $US
|
41 355
+65.9%
|
6,00
|
248 130 $US
|
|
|
2025-03-06 |
2025-03-05 |
A
Achat
|
Administrateur non-exécutif
|
37 835
+151.9%
5,82
220 260 $US
|
37 835
+151.9%
|
5,82
|
220 260 $US
|
|
|
2025-03-06 |
2025-03-04 |
A
Achat
|
Administrateur non-exécutif
|
7 491
+43.0%
6,35
47 544 $US
|
7 491
+43.0%
|
6,35
|
47 544 $US
|
|
|
2025-02-27 |
2025-02-27 |
A
Achat
|
Chief Financial Officer
Dirigeant
|
3 718
+10.2%
5,85
21 750 $US
|
3 718
+10.2%
|
5,85
|
21 750 $US
|
|
|
2025-02-27 |
2025-02-27 |
A
Achat
|
CEO and President
Administrateur exécutif
|
3 000
+0.4%
5,80
17 400 $US
|
3 000
+0.4%
|
5,80
|
17 400 $US
|
|
|
2025-02-27 |
2025-02-26 |
A
Achat
|
CEO and President
Administrateur exécutif
|
4 000
+0.5%
5,70
22 796 $US
|
4 000
+0.5%
|
5,70
|
22 796 $US
|
|
|
2025-02-27 |
2025-02-25 |
A
Achat
|
Chief Financial Officer
Dirigeant
|
6 282
+20.9%
5,59
35 116 $US
|
6 282
+20.9%
|
5,59
|
35 116 $US
|
|
|
2025-02-27 |
2025-02-25 |
A
Achat
|
CEO and President
Administrateur exécutif
|
10 000
+1.3%
5,68
56 765 $US
|
10 000
+1.3%
|
5,68
|
56 765 $US
|
|
|
2025-02-26 |
2025-02-24 |
A
Achat
|
Actionnaire important
|
18 861
+0.4%
6,00
113 147 $US
|
18 861
+0.4%
|
6,00
|
113 147 $US
|
|
|
2025-02-24 |
2025-02-21 |
A
Achat
|
Actionnaire important
|
427 668
+11.4%
5,94
2 540 348 $US
|
427 668
+11.4%
|
5,94
|
2 540 348 $US
|
|
|
2025-02-21 |
2025-02-21 |
A
Achat
|
Chief Financial Officer
Dirigeant
|
5 000
+20.0%
5,85
29 250 $US
|
5 000
+20.0%
|
5,85
|
29 250 $US
|
|
|
2025-02-24 |
2025-02-20 |
A
Achat
|
Actionnaire important
|
612 674
+19.4%
5,92
3 627 030 $US
|
612 674
+19.4%
|
5,92
|
3 627 030 $US
|
|
|
2025-02-21 |
2025-02-20 |
A
Achat
|
Chief Financial Officer
Dirigeant
|
14 500
+138.1%
5,88
85 234 $US
|
14 500
+138.1%
|
5,88
|
85 234 $US
|
|
|
2025-02-21 |
2025-02-19 |
A
Achat
|
Chief Financial Officer
Dirigeant
|
10 500
+inf%
5,51
57 813 $US
|
10 500
+inf%
|
5,51
|
57 813 $US
|
|
|
2024-10-30 |
2024-10-28 |
A
Achat
|
Administrateur non-exécutif
Actionnaire important
|
341 600
+30.2%
18,00
6 148 800 $US
|
341 600
+30.2%
|
18,00
|
6 148 800 $US
|
|
|
2024-10-30 |
2024-10-28 |
A
Achat
|
Administrateur non-exécutif
Actionnaire important
|
3 828 400
+225.8%
18,00
68 911 200 $US
|
3 828 400
+225.8%
|
18,00
|
68 911 200 $US
|
|
|
2024-10-28 |
2024-10-28 |
A
Achat
|
Actionnaire important
|
279 500
+9.7%
18,00
5 031 000 $US
|
279 500
+9.7%
|
18,00
|
5 031 000 $US
|
|
|
2024-10-28 |
2024-10-28 |
A
Achat
|
Actionnaire important
|
370 500
+6.3%
18,00
6 669 000 $US
|
370 500
+6.3%
|
18,00
|
6 669 000 $US
|
|